Lewis v. Becerra
Decision Date | 13 January 2022 |
Docket Number | Civil Action 18-2929 (RBW) |
Court | United States District Courts. United States District Court (Columbia) |
Parties | CAROL A. LEWIS, et al., Plaintiffs, v. XAVIER BECERRA, [1] in his official capacity as Secretary of the Department of Health and Human Services, Defendant. |
The plaintiffs, Carol Lewis and Douglas Sargent, on behalf of themselves and all others similarly situated, bring this civil action against the defendant, Xavier Becerra, in his official capacity as the Secretary (the “Secretary”) of the United States Department of Health & Human Services (the “Department”) pursuant to Title XVIII of the Social Security Act, 42 U.S.C § 1395ff(b), see Class Action Complaint (“Compl.”) ¶ 8, ECF No. 1; the Administrative Procedure Act (“APA”), 5 U.S.C § 706, as modified by 42 U.S.C. § 405(g), see id. ¶¶ 146-63; and the Declaratory Judgment Act, 28 U.S.C. §§ 2201, see id. ¶¶ 164-66.[2] Currently pending before the Court is the plaintiffs' motion for a preliminary injunction to enjoin “the Secretary from continuing to reject [ ] claims based on CMS 1682-R and/or the claim that a [continuous glucose monitor (“CGM”)] is not ‘primarily and customarily used to serve a medical purpose.'” See Plaintiffs' Motion for Preliminary Injunction ( at 2, ECF No. 97. Upon careful consideration of the parties' submissions, [3]the Court concludes for the following reasons that it must deny the plaintiffs' motion.
The Court previously discussed much of the relevant background of this case in detail, see Memorandum Opinion at 2-11 (Jan. 29, 2021), ECF No. 77, and therefore will not reiterate that information again here. The Court will, however, briefly discuss the background of this case as it relates to the issues the Court must consider in deciding the plaintiffs' preliminary injunction motion.
Medicare “Part B is an optional supplemental insurance program that pays for medical items and services . . ., including . . . durable medical equipment.” Ne. Hosp. Corp. v. Sebelius, 657 F.3d 1, 2 (D.C. Cir. 2011) (citing 42 U.S.C. §§ 1395j-1395w-4). However, 42 U.S.C. § 1395y excludes from coverage items and services “not reasonable and necessary for the diagnosis or treatment of illness or injury[.]” 42 U.S.C. § 1395y(a)(1)(A). The Secretary has issued regulations clarifying the definition of “[d]urable medical equipment.” See 42 C.F.R. § 414.202.
Id. The Medicare statute expressly designates “blood-testing strips and blood glucose monitors for individuals with diabetes” as “durable medical equipment” and, therefore, covered. 42 U.S.C. § 1395x(n).
CGMs consist of a “disposable sensor” which “is placed below the skin in the space between tissues (interstitial space) that is filled with fluids going to and from cells.” Compl. ¶ 33. These fluids contain glucose that “is correlated with the glucose in blood itself.” Id. “Current CGM sensors last for a week and measure glucose levels every five to seven minutes (i.e., more than 200 times a day) without requiring patient interaction, including when the patient is sleeping.” Id. The information from the CGM sensors is then Id. ¶ 34. CGMs monitor users' blood glucose levels more frequently than traditional blood glucose monitors, see id. ¶ 36; can “trigger an alert[], ” id. ¶ 34; “may be connected to an insulin pump such that the amount of insulin delivered can be automatically controlled based on the sensed glucose levels[, ]” id.; and “can plot glucose trends and perform further analyses[, ]” id. “Typically, the CGM is calibrated by finger prick/test strip testing twice a day[, ]” though “some newer CGMs do not require calibration. Id. ¶ 35.
Pls.' Mot. at 3 (internal citations omitted). Therefore, unlike blood glucose monitors, CGMs are not covered under Medicare because, as CMS has ruled, they are not “primarily and customarily used to serve a medical purpose” and thus do not constitute “durable medical equipment.” Centers for Medicare & Medicaid Services Ruling 1682-R (Jan. 12, 2017).
Both Lewis and Sargent were denied coverage for CGMs, see Compl. ¶¶ 101-04, 113-25, and the plaintiffs allege that “[b]ased on information produced by the Secretary, it is believed that ~13, 000 claims are denied on the bad faith/illegal grounds each month[, ]” Pls.' Mot. At 2, based on what they argue is the illegal issuance of CMS 1682-R, id. at 8-9, and the conclusion by one district court that the Secretary acted in “bad faith” by issuing the regulation, id. at 7-8.[5]
On September 22, 2021, the plaintiffs filed their motion for a preliminary injunction. See Pls.' Mot. at 1.[6] Thereafter, the defendant filed an opposition on September 29, 2021, see Def.'s Opp'n at 16; the plaintiffs filed a reply on October 6, 2021, see Pls.' Reply at 10; and the defendant was permitted to file a surreply on October 20, 2021, see Def.'s Surreply at 5. A hearing was held on the motion for preliminary injunction on November 22, 2021. See Min. Entry (Nov. 22, 2021).
A party moving for a preliminary injunction must show “(1) a substantial likelihood of success on the merits, (2) that [he or she] would suffer irreparable injury if the injunction were not granted, (3) that an injunction would not substantially injure other interested parties, and (4) that the public interest would be furthered by the injunction.” Chaplaincy of Full Gospel Churches v. England, 454 F.3d 290, 297 (D.C. Cir. 2006). In “seeking a preliminary injunction, the movant has the burden to show that all four factors, taken together, weigh in favor of the injunction.” Abdullah v. Obama, 753 F.3d 193, 197 (D.C. Cir. 2014) (internal quotation marks omitted).[7]
The plaintiffs argue that they are entitled to “a preliminary injunction barring the Secretary from continuing to reject CGM claims based on CMS 1682-R and/or the claim that a CGM is not ‘primarily and customarily used to serve a medical purpose.'” Pls.' Mot. at 2.
According to the plaintiffs, “[t]he Secretary's underlying position on which the claim denials in this case are based is in bad faith, ” id., based in part on the...
To continue reading
Request your trial